Terms: = Cervical cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Treatment
36 results:
1. HIV gp120/Tat protein-induced epithelial-mesenchymal transition promotes the progression of cervical lesions.
Wang P; Yang B; Huang H; Liang P; Long B; Chen L; Yang L; Tang L; Huang L; Liang H
AIDS Res Ther; 2023 Nov; 20(1):82. PubMed ID: 37981694
[TBL] [Abstract] [Full Text] [Related]
2. Neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: A propensity score-matched cohort study.
Wang G; Huang C; Yang K; Guo R; Qiu Y; Li W; Mao Y; Tang L; Ma J
Radiother Oncol; 2022 Dec; 177():205-213. PubMed ID: 36375564
[TBL] [Abstract] [Full Text] [Related]
3. Prediction model for cervical lymph node metastasis in human papillomavirus-related oropharyngeal squamous cell carcinomas.
Joo L; Bae YJ; Choi YJ; Lee YS; Chung SR; Suh CH; Kim SO; Baek JH; Lee JH
Eur Radiol; 2021 Oct; 31(10):7429-7439. PubMed ID: 33779817
[TBL] [Abstract] [Full Text] [Related]
4. PET-CT radiomics by integrating primary tumor and peritumoral areas predicts E-cadherin expression and correlates with pelvic lymph node metastasis in early-stage cervical cancer.
Li XR; Jin JJ; Yu Y; Wang XH; Guo Y; Sun HZ
Eur Radiol; 2021 Aug; 31(8):5967-5979. PubMed ID: 33528626
[TBL] [Abstract] [Full Text] [Related]
5. Dynamic analysis of circulating tumor DNA to predict prognosis and monitor therapeutic response in metastatic relapsed cervical cancer.
Tian X; Ge D; Zhang F; Zhang B; Bai W; Xu X; Li Z; Cao Y; Li P; Zou K; Zou L
Int J Cancer; 2021 Feb; 148(4):921-931. PubMed ID: 33113150
[TBL] [Abstract] [Full Text] [Related]
6. Comparative study on the oncological prognosis of laparoscopy and laparotomy for stage IIA1 cervical squamous cell carcinoma.
Chen C; Fang Z; Wang Q; Li W; Li P; Wang L; Kang S; Zhu B; Lin Z; Wang X; Wang L; Fan H; Bin X; Lang J; Liu P
Eur J Surg Oncol; 2021 Feb; 47(2):346-352. PubMed ID: 32859433
[TBL] [Abstract] [Full Text] [Related]
7. Epigenetic Silencing of LMX1A Contributes to cancer Progression in Lung cancer Cells.
Wu TH; Chang SY; Shih YL; Chian CF; Chang H; Lin YW
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751497
[TBL] [Abstract] [Full Text] [Related]
8. Preliminary survey of 3D image-guided brachytherapy for cervical cancer at representative hospitals in Asian countries.
Okonogi N; Wakatsuki M; Mizuno H; Fukuda S; Cao J; Kodrat H; Lau FN; Calaguas MJ; de Los Reyes RH; Chansilpa Y; Uddin AFMK; Adylkhanov T; Cho CK; Tsegmed U; Hoang NC; Ohno T; Nakano T; Kato S;
J Radiat Res; 2020 Jul; 61(4):608-615. PubMed ID: 32367130
[TBL] [Abstract] [Full Text] [Related]
9. Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the
Hopfensperger KM; Adams Q; Kim Y; Wu X; Xu W; Patwardhan K; Thammavong B; Caster J; Flynn RT
Med Phys; 2020 Jun; 47(5):2061-2071. PubMed ID: 32073669
[TBL] [Abstract] [Full Text] [Related]
10. Radiomic analysis for pretreatment prediction of response to neoadjuvant chemotherapy in locally advanced cervical cancer: A multicentre study.
Sun C; Tian X; Liu Z; Li W; Li P; Chen J; Zhang W; Fang Z; Du P; Duan H; Liu P; Wang L; Chen C; Tian J
EBioMedicine; 2019 Aug; 46():160-169. PubMed ID: 31395503
[TBL] [Abstract] [Full Text] [Related]
11. hsa_circ_0000745 promotes cervical cancer by increasing cell proliferation, migration, and invasion.
Jiao J; Zhang T; Jiao X; Huang T; Zhao L; Ma D; Cui B
J Cell Physiol; 2020 Feb; 235(2):1287-1295. PubMed ID: 31256433
[TBL] [Abstract] [Full Text] [Related]
12. 18F-FDG-PET/CT imaging of uterine cervical cancer recurrence in women with and without HIV infection.
Lawal IO; Ololade KO; Popoola GO; Ankrah AO; Vorster M; Maes A; Mokgoro NP; van de Wiele C; Sathekge MM
Q J Nucl Med Mol Imaging; 2022 Mar; 66(1):52-60. PubMed ID: 31089075
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathological Features and Outcomes of Endoscopic Submucosal Dissection for Superficial cancer of the Pharynx.
Abe M; Iwamuro M; Kawahara Y; Kanzaki H; Kawano S; Tanaka T; Tsumura M; Makino T; Noda Y; Marunaka H; Nishizaki K; Okada H
Acta Med Okayama; 2019 Apr; 73(2):109-115. PubMed ID: 31015745
[TBL] [Abstract] [Full Text] [Related]
14. Examining Urban and Rural Differences in How Distance to Care Influences the Initiation and Completion of treatment among Insured cervical cancer Patients.
Spees LP; Brewster WR; Varia MA; Weinberger M; Baggett C; Zhou X; Petermann VM; Wheeler SB
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):882-889. PubMed ID: 30733307
[TBL] [Abstract] [Full Text] [Related]
15. Evaluating the urban-rural paradox: The complicated relationship between distance and the receipt of guideline-concordant care among cervical cancer patients.
Spees LP; Wheeler SB; Varia M; Weinberger M; Baggett CD; Zhou X; Petermann VM; Brewster WR
Gynecol Oncol; 2019 Jan; 152(1):112-118. PubMed ID: 30442384
[TBL] [Abstract] [Full Text] [Related]
16. Expanding the Single-Visit Approach for cervical cancer Prevention: Successes and Lessons From Burkina Faso.
Ouedraogo Y; Furlane G; Fruhauf T; Badolo O; Bonkoungou M; Pleah T; Lankoande J; Bicaba I; Bazant ES
Glob Health Sci Pract; 2018 Jun; 6(2):288-298. PubMed ID: 29959272
[TBL] [Abstract] [Full Text] [Related]
17. Surgical and Oncologic Outcomes of Radical Abdominal Trachelectomy Versus Hysterectomy for Stage IA2-IB1 cervical cancer.
Guo J; Zhang Y; Chen X; Sun L; Chen K; Sheng X
J Minim Invasive Gynecol; 2019; 26(3):484-491. PubMed ID: 29908338
[TBL] [Abstract] [Full Text] [Related]
18. Cost-Effectiveness Analysis of the Introduction of HPV Vaccination of 9-Year-Old-Girls in Iran.
Yaghoubi M; Nojomi M; Vaezi A; Erfani V; Mahmoudi S; Ezoji K; Zahraei SM; Chaudhri I; Moradi-Lakeh M
Value Health Reg Issues; 2018 May; 15():112-119. PubMed ID: 29698864
[TBL] [Abstract] [Full Text] [Related]
19. Postoperative chemotherapy for node-positive cervical cancer: Results of a multicenter phase II trial (JGOG1067).
Matoda M; Takeshima N; Michimae H; Iwata T; Yokota H; Torii Y; Yamamoto Y; Takehara K; Nishio S; Takano H; Mizuno M; Takahashi Y; Takei Y; Hasegawa T; Mikami M; Enomoto T; Aoki D; Sugiyama T
Gynecol Oncol; 2018 Jun; 149(3):513-519. PubMed ID: 29661497
[TBL] [Abstract] [Full Text] [Related]
20. Do fertile women have an inferior treatment for high-grade precancerous lesions?
Kim M; Cho HY; Lee J; Suh DH; Kim K; No JH; Kim YB
J Obstet Gynaecol Res; 2018 Apr; 44(4):772-777. PubMed ID: 29369475
[TBL] [Abstract] [Full Text] [Related]
[Next]
